KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Current Assets (2016 - 2025)

Historic Current Assets for Amgen (AMGN) over the last 17 years, with Q4 2025 value amounting to $29.1 billion.

  • Amgen's Current Assets rose 9.3% to $29.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $29.1 billion, marking a year-over-year increase of 9.3%. This contributed to the annual value of $29.1 billion for FY2025, which is 9.3% up from last year.
  • As of Q4 2025, Amgen's Current Assets stood at $29.1 billion, which was up 9.3% from $27.9 billion recorded in Q3 2025.
  • Amgen's 5-year Current Assets high stood at $48.5 billion for Q3 2023, and its period low was $18.5 billion during Q1 2022.
  • Over the past 5 years, Amgen's median Current Assets value was $26.8 billion (recorded in 2024), while the average stood at $28.0 billion.
  • Its Current Assets has fluctuated over the past 5 years, first skyrocketed by 14521.27% in 2023, then tumbled by 4478.62% in 2024.
  • Quarter analysis of 5 years shows Amgen's Current Assets stood at $19.4 billion in 2021, then increased by 14.45% to $22.2 billion in 2022, then skyrocketed by 36.72% to $30.3 billion in 2023, then fell by 4.29% to $29.0 billion in 2024, then increased by 0.09% to $29.1 billion in 2025.
  • Its last three reported values are $29.1 billion in Q4 2025, $27.9 billion for Q3 2025, and $26.7 billion during Q2 2025.